SLC60A1 and gastric cancer: Our findings that the levels of MFSD4 mRNA in GC tissues serve as an independent risk factor for hepatic recurrence and metastasis indicates the potential of MFSD4 expression as a novel diagnostic or predictive biomarker for hepatic metastasis in patients with GC.